NCT07436767 Safety and Efficacy of KL003 Cell Injection in Severe Sickle Cell Disease Status NOT_YET_RECRUITING Phase NA
NCT07432867 Efficacy Safety Study of Gene Therapy for Sickle Cell DiseaseSCD Using Autologous CD34+ Cells Transduced ex Vivo, Carrying a Corrected Globin Gene and a Silencing RNA. Status RECRUITING Phase PHASE1/PHASE2
NCT07431398 Single-dose Pharmacokinetics of Pociredir in Participants With Sickle Cell Disease Status TERMINATED Phase PHASE1
NCT07402811 Mindfulness-Based Intervention for Pain and Sleep in Adolescents and Young Adults With Sickle Cell Disease Status RECRUITING Phase NA
NCT07401823 Open-Label Extension Study to Pioneer Study 6058-SCD-101 Status ENROLLING_BY_INVITATION Phase PHASE2
NCT07373639 A Long-term Follow-up Study in Patients Who Received BEAM-101 Status RECRUITING Phase N/A
NCT07369024 Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults Status RECRUITING Phase PHASE2
NCT07356050 Verifying Antibodies After Live Immunization Delivery (VALID): A Study of Measles Vaccine Immunogenicity in Children With Sickle Cell Disease Status RECRUITING Phase N/A
NCT07341022 STEM CELL MOBILIZATION WITH HIGH-DOSE PLERIXAFOR IN PATIENTS WITH SICKLE CELL DISEASE Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT07316478 Stress Management and Mindfulness Intervention for Patients With Sickle Cell Disease Status RECRUITING Phase NA
NCT07282210 Efficacy and Safety of SIL-8301 for Control of Hemolysis in a Uniform Sickle Cell Disease Endotype Status RECRUITING Phase PHASE2
NCT07252050 Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease Status RECRUITING Phase PHASE1/PHASE2
NCT07247188 Study of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and Adolescents With Sickle Cell Disease Status RECRUITING Phase PHASE3
NCT07246265 Morphine Clearance and Glomerular Filtration in Sickle Cell Patients in Crisis in Intensive Care Status RECRUITING Phase NA
NCT07226219 Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease Status RECRUITING Phase PHASE1
NCT07224360 Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD) Status RECRUITING Phase PHASE2
NCT07222475 Writing Relaxing Beats in Adolescents Who Have Sickle Cell Disease Status RECRUITING Phase NA
NCT07200869 Outcomes of Vaso-occlusive Crisis in Pediatric Sickle Cell Disease Status NOT_YET_RECRUITING Phase N/A